Haemonetics Corp (HAE)
95.73
+0.93
(+0.98%)
USD |
NYSE |
May 17, 16:00
95.76
+0.02
(+0.03%)
Pre-Market: 20:00
Haemonetics Revenue (Annual): 1.309B for March 31, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.309B |
| March 31, 2023 | 1.169B |
| March 31, 2022 | 993.20M |
| March 31, 2021 | 870.46M |
| March 31, 2020 | 988.48M |
| March 31, 2019 | 967.58M |
| March 31, 2018 | 903.92M |
| March 31, 2017 | 886.12M |
| March 31, 2016 | 908.83M |
| March 31, 2015 | 910.37M |
| March 31, 2014 | 938.51M |
| March 31, 2013 | 891.99M |
| March 31, 2012 | 727.84M |
| March 31, 2011 | 676.69M |
| March 31, 2010 | 645.43M |
| March 31, 2009 | 597.88M |
| March 31, 2008 | 516.44M |
| Date | Value |
|---|---|
| March 31, 2007 | 449.61M |
| March 31, 2006 | 419.73M |
| March 31, 2005 | 383.60M |
| March 31, 2004 | 364.23M |
| March 31, 2003 | 336.96M |
| March 31, 2002 | 319.97M |
| March 31, 2001 | 293.86M |
| March 31, 2000 | 280.61M |
| March 31, 1999 | 284.51M |
| March 31, 1998 | 285.80M |
| March 31, 1997 | 303.00M |
| March 31, 1996 | 278.20M |
| March 31, 1995 | 262.40M |
| March 31, 1994 | 248.40M |
| March 31, 1993 | 216.30M |
| March 31, 1992 | 176.40M |
| March 31, 1991 | 157.30M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
870.46M
Minimum
2021
1.309B
Maximum
2024
1.066B
Average
993.20M
Median
2022
Revenue (Annual) Benchmarks
| ResMed Inc | 4.223B |
| Stryker Corp | 20.50B |
| Masimo Corp | 2.048B |
| Insulet Corp | 1.697B |
| InfuSystems Holdings Inc | 125.78M |